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Available online 24 August 2016Chronic exposure to elevated levels of glucocorticoids can exert a neurotoxic effect in patients, possiblymanifest-
ing asmolecular imaging alterations in patients. The aim of this studywas to investigate the potential association
between brain metabolism and elevated hormone level using 18F-ﬂuorodeoxyglucose positron emission tomog-
raphy. We retrospectively enrolled 92 consecutive patients with conﬁrmed diagnosis of Cushing's disease. A
voxel-based analysis was performed to investigate the association between cerebral 18F-ﬂuorodeoxyglucose up-
take and serumcortisol level. Relatively impairedmetabolism of speciﬁc brain regions correlatedwith serumcor-
tisol level was found. Speciﬁcally, notable correlations were found in the hippocampus, amygdala, and
cerebellum, regions considered to be involved in the regulation and central action of glucocorticoids. Moreover,
some hormone-associated regions were found in the frontal and occipital cortex, possibly mediating the cogni-
tive changes seen in Cushing's disease. Our ﬁndings link patterns of perturbed brain metabolism relates to indi-
vidual hormone level, thus presenting a substrate for cognitive disturbances seen in Cushing's disease patients, as
well as in other conditions with abnormal cortisol levels.






For nearly half a century, the brain has been recognized as a target
organ for plasma glucocorticoids (Martignoni et al., 1992). Although
the mechanism of central action of hormones derived from circulation
is far from clear, an increasing number of studies have linked excessive
plasma glucocorticoids with cognitive symptoms in otherwise normal
subjects, as well as in patients with disorders in which glucocorticoids
have been implicated, notably major depression, Alzheimer's disease,
and organic psychoses (Belanoff et al., 2001). In particular, Cushing's
disease (CD) presents a unique human model to investigate brain
changes resulting from chronic endogenous cortisol overexposure
(Newell-Price et al., 2006).
It is well-established that excessive glucocorticoids can exert a neu-
rotoxic effect (McEwen, 2007). The cognitive impairments of CD-ﬂuorodeoxyglucose positron
rmone; HPA, hypothalamic–
edicine, Peking Union Medical
es and Peking Union Medical
).
is work.
. This is an open access article underpatients include concentration, learning, and memory deﬁcits, as well
as mood disorders such as depression, euphoria, and anxiety (Forget
et al., 2000). Besides these neuropsychiatric symptoms, excessive gluco-
corticoid exposure in CD patients can cause structural abnormalities in
radiological brain images. Indeed, previous studies have demonstrated
that brain volume (Bourdeau et al., 2002; Momose et al., 1971) is signif-
icantly decreased among patients with excessive glucocorticoid expo-
sure. The hippocampus, a brain area involved in regulating the
secretion of glucocorticoids (Herman et al., 2005; Jacobson and
Sapolsky, 1991), has shown structural and functional changes in such
patients (Maheu et al., 2008; Starkman et al., 1992). In general, the de-
tection of perturbed brain structure and function by medical imaging is
an important tool to exploremechanisms underlying the cognitive com-
plaints of CD patients, and can also help to reveal how excessive hor-
mone levels might interfere with brain health.
[18F]Fluorodeoxyglucose positron emission tomography (FDG PET)
presents an important method for metabolic brain imaging, and has
been widely used in evaluating compromised brain function in
Alzheimer's disease as well as other conditionsmanifesting in cognitive
disorders (Habeck et al., 2012; Robert et al., 2012). To date, no studies
have investigated the relationship between FDG PET measurements of
brain metabolism and individual hormone level in CD patients using
voxel-based methods. In the current study we enrolled a largethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1




Median (range) 35 (18–65)
Gender
Male (%) 26 (28)
Female (%) 66 (72)
Cortisone (μg/dl) (mean ± S.D.) 28.3 ± 10.4
ACTH (pg/ml) (mean ± S.D.) 98.3 ± 80.8
ACTH = adrenocorticotropic hormone.
416 S. Liu et al. / NeuroImage: Clinical 12 (2016) 415–419consecutive cohort of CD patients for FDG PET investigation. We per-
formed a voxel-based statistical comparison to identify the anatomical
correlations between brain metabolism and individual hormone alter-
ation in CD patients.
2. Materials and methods
2.1. Patients
The current study retrospectively enrolled 92 consecutive CD pa-
tients treated at Peking Union Medical College Hospital between Janu-
ary 2010 and January 2015. The patients included in this study met
the following criteria: adults with conﬁrmed diagnosis of CD; informed
consent for a presurgical PET scan; presurgical examination for serum
cortisol and serum adrenocorticotropic hormone (ACTH) levels; no
prior craniotomy or stereotactic biopsy. All patients were diagnosed
with CD at the Endocrinology and/or Neurosurgery division of our hos-
pital (78 patients had a pathology-based diagnosis of a pituitary tumor).
Laboratory tests of the 8 AM serum cortisol and ACTH concentrations
were performed for all patients; the laboratory tests were obtained
using standard procedureswithin 1month of the PET acquisition. All re-
search activities in this studywere approved by the Ethics Committee of
our hospital, and all patients provided informed consent.
2.2. Image acquisition
The PET data were acquired on a Biograph 64 TruePoint TrueV PET/
CT system (Siemens Medical Solutions, Erlangen, Germany). FDG was
produced on-site using a RDS-111 Cyclotron (CTI, Knoxville, TN, USA)
and standard procedures for FDG production. Before the PET examina-
tions, the patients were required to fast for at least 4 h; the level of
blood glucose in each patient was conﬁrmed to be within normal limits
(b6.4 mM). We administered FDG intravenously at a dose of 5.55 MBq
(0.15 mCi) per kilogram of body weight.
2.3. Spatial normalization and reference scaling of FDG PET images
Images from all subjects were registered at the Montreal Neurologi-
cal Institute space using SPM8 (http://www.ﬁl.ion.ucl.ac.uk/spm/
software/spm8) and spatially smoothed with a Gaussian kernel at a
full width at half maximum of 6 mm. Considering the well-known var-
iation of the baseline cerebral metabolism between subjects, FDG up-
take data were normalized to the mean global cerebral intensity.
2.4. Voxel-based analysis
To evaluate the association between brain metabolism and the
serum hormone levels, a voxel-based analysis was performed using
the following general linear model:
Y ¼ Hormone;Age; Sex;1ð Þ  βþ ε
For each voxel, Y represents the FDG PET signal in each individual
patient, Hormone represents the serum cortisol, Age and Sex denote
the age and the sex (1=male, 0= female) of the patients, respectively,
1 represents the intercept term,β represents themodel parameter to be
estimated, and ε is the estimated residual. The resultswere displayed on
a template brain at a signiﬁcance threshold of probability value
(p b 0.05) and a minimum cluster size of 50 contiguous voxels. The re-
sults were then corrected by a permutation test (Chen and Herskovits,
2010) (n=1000) using a randomized ranking of hormone level. The es-
timated beta values for each hormonewere recorded to form a distribu-
tion of the regression coefﬁcient. Only voxels with an original p-value
less than the 95% p-values based on the permutation test were consid-
ered signiﬁcant.2.5. Evaluation of the hormone associated brain regions
Based on the method described above, we identiﬁed voxel clusters
with a signiﬁcant association between brainmetabolismand serum cor-
tisol. Themean normalizedmetabolism value of the positively and neg-
atively correlated clusters was calculated separately for each patient.
Pearson correlation analysis was performed to investigate the associa-
tion between the serum cortisol and the mean value of the clusters for
each patient.
2.6. Statistical analysis
The general linear model and permutation test were performed for
voxel-based analysis by using Matlab (R2012a, MathWorks, Natick,
MA, USA). Pearson correlation was performed to investigate the associ-
ation between brain metabolism of the clusters identiﬁed by voxel-
based analysis and serum cortisol by using Prism (6.0c, GraphPad Soft-
ware, San Diego, CA, USA). In this study, a p-value of b0.05 indicated a
signiﬁcant difference.
3. Results
3.1. Demographic and clinical data
We systematically reviewed a total of 92 CD patients, 78 of whom
had diagnosis of pituitary adenoma conﬁrmedby pathological examina-
tion of surgical specimens. Of the patients, 26 (28%) were male and 66
(72%) were female, with a median age of 35 years old (range, 18–
65 years old). Themean serumcortisol and serumACTH levels of the pa-
tientswere 28.3 μg/dL and 98.3 pg/mL, respectively. The detailed clinical
characteristics of the patients are shown in Table 1.
3.2. Voxel-based analysis ﬁndings
The anatomical correlation between brain energy metabolism and
individual hormone level was identiﬁed using voxel-based analysis.
Clusters showing a signiﬁcant association between brain metabolism
and serumcortisol levels are shown in Fig. 1. The clusterswith a positive
correlation between relative FDG uptake and serum cortisol levels were
preferentially located in the anteromedial temporal lobe including
the hippocampus and amygdala, the insular cortex, and the cerebel-
lum. Meanwhile, the regions where relative brain metabolism was
negatively correlated with the serum cortisol levels were mainly in
the lateral frontal cortex, medial and posterior occipital cortex,
head of the caudate nucleus, and the anterior cingulate gyrus.
Allowing to see the inside structures more clearly, we made a ren-
dering image with cutouts (Fig. 2).
3.3. Correlations of hormone level and brain metabolism
The results of correlations between the serum cortisol level and the
metabolism of the clusters are shown in Fig. 3. A statistically signiﬁcant
correlation was found between the cortisol level and the mean
Fig. 1. Coronal and axial slices for the topography of associations between FDG PET measures of brain metabolism and serum cortisol (minimum cluster size = 50 voxels). Brain clusters
with signiﬁcant positive correlations are shown in red color and the negative correlations are in blue. The color range indicates the level of−lgp (−log10p) value from dark to light.
417S. Liu et al. / NeuroImage: Clinical 12 (2016) 415–419metabolism value of the positively correlated cluster (r = 0.436,
p b 0.0001) (Fig. 3A). In addition, a signiﬁcant inverse correlation be-
tween the cortisol level and themeanmetabolismvalue of the negative-
ly correlated cluster was found (r=−0.652, p b 0.0001) (Fig. 3B).4. Discussion
In this study, we examined the voxel-based association of brain en-
ergy metabolism and serum hormone level in patients diagnosed with
CD. Notably, we found signiﬁcant correlations between the individual
serum cortisol and the FDG uptake in particular brain regions, including
the hippocampus, amygdala, anterior cingulate cortex, and cerebellum,
all of which regions have been implicated in the regulation and action of
glucocorticoids. Some additional associations between hormone levels
and cerebral metabolism were found in the frontal and occipital cortex.
Moreover, we examined these clusters for each patient and found good
correlations between the FDGuptake andhormone level. Theseﬁndings
provide evidence for functionally relevant associations between brain
function and serum level of hormone.Fig. 2. Rendering images were shown for providing an overall view. The red clusters
indicate signiﬁcant positive correlations and the blue clusters indicate negative. Brain
regions associated with the regulation and action of glucocorticoids, speciﬁcally, the
hippocampus, amygdala, anterior cingulate cortex, and cerebellum are signiﬁcantly
correlated with the serum cortisol levels of patients.Excessive glucocorticoids affect the morphology and function of the
hippocampus, which plays an important role in modulating the activity
of the hypothalamic-pituitary-adrenal (HPA) axis via a negative feed-
back loop involving glucocorticoid binding receptors (Herman et al.,
2005; Jacobson and Sapolsky, 1991). Several neuroimaging studies
have found that patients with high glucocorticoid levels have a de-
creased hippocampal volume (Lupien et al., 1998; Starkman et al.,
1992), which might be considered an ominous result, implying a risk
for cognitive deﬁcits. Indeed, other studies have suggested that elevated
cortisol levels are associated with damage to hippocampal glucocorti-
coid receptors (Sapolsky et al., 1986). In the current study, we explored
the association between elevated cortisol level in CD patients and al-
tered brain energy metabolism. Speciﬁcally, we found the relative FDG
metabolism in the hippocampus to be positively correlatedwith the pa-
tients' serum cortisol level. This correlation may reveal a functional dis-
order involving hippocampal energymetabolism, and is consistentwith
the known role of glucocorticoids in modulating uptake and utilization
of glucose in the hippocampus (Horner et al., 1990; Virgin et al., 1991).
The neuroimagingﬁndings of hippocampal atrophy do not necessar-
ily imply a permanent loss of neurons. Studies on stress, which involves
excessive glucocorticoids, showed conﬂicting data on hippocampal
damages. Studies on rats found glucocorticoids exposure or chronic
stress caused a loss of neurons in the hippocampus (Sapolsky, 1985).
However, following studies in rodents and non-human primates did
not reveal massive neuronal loss or obvious neuropathological changes
following glucocorticoids exposure or chronic stress (Pravosudov and
Omanska, 2005; Vollmann-Honsdorf et al., 1997). In the current study,
the present ﬁndings of increased FDG uptakemay indicate that the hip-
pocampus is metabolically stressed, instead of neuronal loss, which
would likely have resulted in hypometabolism. The atrophy of the hip-
pocampus is likely to be functional disorders rather than permanent
damages. Evidence from the clinical practice is after effective treat-
ments, the decreased hippocampal volume associated with sustained
hypercortisolemia in CD patients was reversible, at least in part, once
cortisol levels decreased (Starkman et al., 1999). A number of subse-
quent studies likewise found similar hippocampal volume increases
after correction of hypercortisolism (Bourdeau et al., 2002; Hook et al.,
2007). In addition, the cognitive function of such patients also improved
signiﬁcantly (Hook et al., 2007; Mauri et al., 1993). Apparently, it is
Fig. 3. Correlations of serum cortisol level and brain metabolism value. Pearson analysis was performed between serum cortisol and mean normalized brain metabolism value of the
positively/negatively correlated clusters separately for each patient. A, Signiﬁcant correlation between the cortisol level and metabolism value of the positively correlated cluster (r =
0.436, p b 0.0001). B, Signiﬁcant inverse correlation between the cortisol level and metabolism value of the negatively correlated cluster (r=−0.652, p b 0.0001).
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For studies on humanbeings, it is difﬁcult to get tissues of the brain from
patients exposed to excessive glucocorticoids. Our ﬁndings, from the
view of metabolism of the brain, indicate the possible relationship be-
tween hippocampal changes and glucocorticoids exposure.
Other than in the hippocampus, a high expression of glucocorticoid
receptors is also characteristic of the amygdala and cerebellum
(Hawrylycz et al., 2012). Previous studies have found that the amygdala
plays a role in glucocorticoid secretion during stress (Gray et al., 1989),
and indeed, a recent functional imaging study in CD patients has dem-
onstrated the occurrence of functional alterations in amygdala (Maheu
et al., 2008). Meanwhile, the cerebellum is now understood to partici-
pate in cognitive and emotional processes, extending beyond its classi-
cal motor functions (Luna-Lario et al., 2011). The cerebellum is also
susceptible to increased cortisol levels (Teicher et al., 2003), such that
the cerebellar cortex volume is reduced in patients with active CD
(Santos et al., 2014). Upon achieving long-term remission, volume in-
creases have been observed in the left posterior lobe of the cerebellum
in CD patients (Andela et al., 2013). In the current study, we found
that the relative energy metabolism in the amygdala and cerebellum
was positively correlated with the serum cortisol level in our CD pa-
tients. Based on arguments proposed for our hippocampus ﬁndings,
we hypothesize that we are seeing metabolic activation that should be
rectiﬁed upon normalization of serum cortisol levels.
Besides the limbic systemand cerebellummentioned above, theme-
tabolism of the brain neocortex was also perturbed in our CD patients.
Previous studies on stress have implicated cortical sites, especially re-
gions in the frontal cortex, to be involved in regulating the HPA-axis ac-
tivity (Diorio et al., 1993). In addition, recent studies in rats have
suggested that the medial frontal cortex and anterior cingulate are in-
volved in glucocorticoid regulation (Sullivan and Gratton, 2002). Ac-
cordingly, reduction of the anterior cingulate cortex volume also has
been found in animals exposed to hypercortisolism (Cerqueira et al.,
2005) as well as in elderly humans with dysregulation of the HPA axis
(MacLullich et al., 2006). Moreover, a previous study has demonstrated
that the insular cortex is involved in regulating glucocorticoid effects on
memory consolidation in rats (Fornari et al., 2012). In the present study,
we found that FDG uptake in a number of frontal cortex clusters, specif-
ically including the anterior cingulate cortex and occipital cortex, was
negatively associated with the serum cortisol levels. Meanwhile, the
FDG uptake in the right insular cortex was positively associated with
the serum cortisol levels. These glucocorticoid-associated loci of metab-
olism in the cortex may generate hypotheses for investigating higher
cognitive functional damage in patients with excessive glucocorticoids.
After examining these brain regions from voxel-based analysis, we
found themetabolism patterns signiﬁcantly correlated with serum cor-
tisol levels in CD patients, further demonstrating the association be-
tween brain metabolism and the hormone level. In addition, thisﬁnding indicates that a consensus of information about brain metabo-
lismmay help to evaluate the brain functions and efﬁcacy of treatments
in patients with elevated glucocorticoids.
There are several limitations in our study. Due to the exploratory na-
ture of our study, we could not explain all statistically signiﬁcant associ-
ations of regional brain metabolism and hormone levels. We hope that
future studies will reveal the speciﬁc mechanisms by which these hor-
mones affect brain metabolism. Furthermore, for imaging studies
based on voxel-based statistical mapping, registration and normaliza-
tion procedures present certain caveats. In our study, we completed a
more stringent identiﬁcation of clusters using the permutation test.
Finally, for lack of magnetic resonance imaging data in the current
study, we could not perform volumetric analysis of the brain regions
with metabolic changes associatedwith serum cortisol. We hope future
studies will investigate the structural and metabolic associations of the
brain in patients with CD.
In summary, the current study provides quantitative evidence to
suggest the association between brain metabolism and plasma level of
cortisol in a large series of CDpatients. Our ﬁndings imply that hormone
inﬂuences themetabolic activity in speciﬁc brain regions, notably those
with abundant corticosteroid receptors, and thus will facilitate explora-
tion of themechanisms of cognitive disorders in patientswith abnormal
glucocorticoid levels.
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